Seoul, South Korea

Kweon Haeng Lee

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Hub Washington Inc.. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kweon Haeng Lee. Retrieved from https://idiyas.com/inventor/kweon-haeng-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kweon Haeng Lee: Innovator in Neuropathic Pain and Muscle Cramp Treatments

Introduction

Kweon Haeng Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of muscle cramps and neuropathic pain. With a total of 2 patents, his work focuses on the innovative use of choline alfoscerate as an active ingredient in various therapeutic compositions.

Latest Patents

Kweon Haeng Lee's latest patents include a composition and method for treating muscle cramps that contains choline alfoscerate. This drug is known for its ability to improve cerebrovascular diseases and brain metabolism. It has a proven safety profile, showing no adverse effects on the kidney and liver, and no severe side effects have been reported. When administered to patients suffering from muscle cramps, choline alfoscerate can significantly alleviate pain and reduce the frequency of cramps. This makes it a valuable component in pharmaceutical compositions aimed at treating or preventing muscle cramps, as well as in health functional food compositions designed to improve muscle health.

Another notable patent by Lee is a composition and method for treating, relieving, or preventing neuropathic pain, also utilizing choline alfoscerate. This drug is effective in addressing cognitive dysfunction associated with cerebrovascular and degenerative brain diseases. Similar to its application in muscle cramps, choline alfoscerate has demonstrated safety and efficacy in reducing pain intensity and occurrence of neuropathic pain when administered to patients. This positions it as a key ingredient in both pharmaceutical and health functional food compositions aimed at managing neuropathic pain.

Career Highlights

Kweon Haeng Lee is currently associated with Hub Washington Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing safe and effective treatments for common yet challenging health issues.

Collaborations

Lee collaborates with talented individuals such as Jun-Ho Yeo and Young Seul Lim, contributing to a dynamic research environment that fosters innovation and development in the field of pharmaceuticals.

Conclusion

Kweon Haeng Lee's contributions to the treatment of muscle cramps and neuropathic pain through his innovative use of choline alfoscerate highlight his role as a significant inventor in the pharmaceutical industry. His work not only addresses critical health issues

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…